Skip to content

Blood brain barrier permeability and inflammatory biomarkers in patients with depression

Blood brain barrier permeability and inflammatory biomarkers in patients with depression - DEFLAME

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00022091
Enrollment
100
Registered
2023-07-06
Start date
2020-09-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32.2 F32.3 F33.2 F33.3

Interventions

Group 1: Patients with a recurrent depression disorder, currently severe episode and patients with a severe depressive episode Group 2: Healthy controls

Sponsors

Klinik für Psychiatrie, Psychosomatik und PsychotherapieUniversitätsklinikum Frankfurt
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Patients: - Presence of a severe single or recurrent depressive disorder with or without psychotic symptoms (according to ICD 10: F32.2, F32.3, F33.2, F33.3) - ability to give consent Healthy controls: - Ability to give consent

Exclusion criteria

Exclusion criteria: Patients: - Presence of a severe somatic or neurological disease - Pregnancy and breastfeeding Healthy controls: - Presence of a psychiatric, severe somatic or neurological disease - Pregnancy and breastfeeding

Design outcomes

Primary

MeasureTime frame
At the time of a high symptom load: cMRI, blood sampling (determination of various inflammation parameters, including interleukins, CRP), questionnaires (including QIDS, MADRS). At the time of remission, but at the latest after 6 months, the same examinations are carried out. In the healthy control subjects, the above-mentioned examinations are performed only once.

Secondary

MeasureTime frame
Development of an individual inflammatory profile per participant and correlation of the same with imaging parameters

Countries

Germany

Contacts

Public ContactMareike Aichholzer

Klinik für Psychiatrie, Psychosomatik und Psychotherapie, Universitätsklinikum Frankfurt

mareike.aichholzer@kgu.de+49 69 6301 5222

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026